» Articles » PMID: 9600479

Time to Clinical Stability in Patients Hospitalized with Community-acquired Pneumonia: Implications for Practice Guidelines

Overview
Journal JAMA
Specialty General Medicine
Date 1998 May 26
PMID 9600479
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Many groups have developed guidelines to shorten hospital length of stay in pneumonia in order to decrease costs, but the length of time until a patient hospitalized with pneumonia becomes clinically stable has not been established.

Objective: To describe the time to resolution of abnormalities in vital signs, ability to eat, and mental status in patients with community-acquired pneumonia and assess clinical outcomes after achieving stability.

Design: Prospective, multicenter, observational cohort study.

Setting: Three university and 1 community teaching hospital in Boston, Mass, Pittsburgh, Pa, and Halifax, Nova Scotia.

Patients: Six hundred eighty-six adults hospitalized with community-acquired pneumonia.

Main Outcome Measures: Time to resolution of vital signs, ability to eat, mental status, hospital length of stay, and admission to an intensive care, coronary care, or telemetry unit.

Results: The median time to stability was 2 days for heart rate (< or =100 beats/min) and systolic blood pressure (> or =90 mm Hg), and 3 days for respiratory rate (< or =24 breaths/min), oxygen saturation (> or =90%), and temperature (< or =37.2 degrees C [99 degrees F]). The median time to overall clinical stability was 3 days for the most lenient definition of stability and 7 days for the most conservative definition. Patients with more severe cases of pneumonia at presentation took longer to reach stability. Once stability was achieved, clinical deterioration requiring intensive care, coronary care, or telemetry monitoring occurred in 1% of cases or fewer. Between 65% to 86% of patients stayed in the hospital more than 1 day after reaching stability, and fewer than 29% to 46% were converted to oral antibiotics within 1 day of stability, depending on the definition of stability.

Conclusions: Our estimates of time to stability in pneumonia and explicit criteria for defining stability can provide an evidence-based estimate of optimal length of stay, and outline a clinically sensible approach to improving the efficiency of inpatient management.

Citing Articles

Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalities.

Kleymann J, Bruckmann S, Langner S, Koschel D, Kolditz M BMC Pulm Med. 2024; 24(1):631.

PMID: 39716184 PMC: 11667939. DOI: 10.1186/s12890-024-03449-0.


Determinants of non-adherence to antibiotic treatment guidelines in hospitalized adults with suspected community-acquired pneumonia: a prospective study.

Lunde Markussen D, Wathne J, Ritz C, van Werkhoven C, Serigstad S, Bjorneklett R Antimicrob Resist Infect Control. 2024; 13(1):140.

PMID: 39580437 PMC: 11585212. DOI: 10.1186/s13756-024-01494-2.


Community-Acquired Pneumonia in the Immunocompromised Patients: An Observational Study from a Single Center, TURKEY.

Yilmaz E, Benli A, Basaran S, Simsek-Yavuz S, Cagatay A, Oncul M Infect Drug Resist. 2024; 17:4875-4885.

PMID: 39524981 PMC: 11550708. DOI: 10.2147/IDR.S480520.


Agreement and comparative accuracy of instability criteria at discharge for predicting adverse events in patients with community-acquired pneumonia.

Danjou A, Bouisse M, Boussat B, Blaise S, Gaillat J, Francois P BMJ Open Respir Res. 2024; 11(1).

PMID: 39510793 PMC: 11551989. DOI: 10.1136/bmjresp-2024-002289.


Proteomic profiling of neutrophils and plasma in community-acquired pneumonia reveals crucial proteins in diverse biological pathways linked to clinical outcome.

Michels E, Chouchane O, de Brabander J, de Vos A, Faber D, Douma R Front Immunol. 2024; 15:1470383.

PMID: 39493755 PMC: 11527607. DOI: 10.3389/fimmu.2024.1470383.